The Israel Innovation Authority, NVIDIA, Teva, Sheba, CytoReason, TerraCyte, MeMed, Weizmann, Technion, BGU, and others will establish a NIS 70 million consortium to develop the next generation of AI applications in biology, therapy discovery, and personalized medicine.
$23.3 million for personized medicine
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.